Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Advanced glycation end products dietary restriction effects on bacterial gut microbiota in peritoneal dialysis patients; a randomized open label controlled trial.
Journal: PloS one
Published: June 29, 2017
HIPK2 is a new drug target for anti-fibrosis therapy in kidney disease.
Journal: Frontiers in physiology
Published: February 14, 2015
Showing 1-2 of 2
Last Updated: 09/26/2026